Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
Felicia Ceban, Joshua D. Rosenblat, Kevin Kratiuk, et al.
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 925-934
Closed Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110609-110609
Closed Access | Times Cited: 12
Biomarkers of ketamine's antidepressant effect: An umbrella review
Shakila Meshkat, Roger Ho, Bing Cao, et al.
Journal of Affective Disorders (2022) Vol. 323, pp. 598-606
Open Access | Times Cited: 12
Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety
Johannes Hauser, Jan Sarlon, Timur Liwinski, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Evidence for the Contribution of the miR-206/BDNF Pathway in the Pathophysiology of Depression
Yabin Zheng, Xiang Jin
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 10
Open Access | Times Cited: 2
Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
Peng Liu, Shanshan Zhang, Yun Liang, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 2855-2865
Open Access | Times Cited: 11
Ketamine use in pediatric depression: A systematic review
Shakila Meshkat, Joshua D. Rosenblat, Roger Ho, et al.
Psychiatry Research (2022) Vol. 317, pp. 114911-114911
Closed Access | Times Cited: 10
Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability
Michael D. Kritzer, Chi‐Un Pae, Prakash S. Masand
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 725-732
Open Access | Times Cited: 9
Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
Ryan Yip, Jennifer Swainson, Atul Khullar, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 9
Low-dose Esketamine suppresses NLRP3-mediated apoptotic and pyroptotic cell death in microglial cells to ameliorate LPS-induced depression via ablating GSK-3β
Sen Zhou, Yang Liu, Binbin Xue, et al.
Behavioural Brain Research (2023) Vol. 459, pp. 114782-114782
Closed Access | Times Cited: 5
Microbiota-Gut-Brain Axis and Antidepressant Treatment
David Antoine Lachmansingh, Aonghus Lavelle, John F. Cryan, et al.
Current topics in behavioral neurosciences (2023), pp. 175-216
Closed Access | Times Cited: 4
Implementation of a ketamine programme for treatment-resistant depression in the public health system: Lessons from the first Australian public hospital clinic
Nicollette Thornton, Dean Wright, Nick Glozier
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 7, pp. 549-554
Open Access | Times Cited: 1
Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis
Jiafeng Li, Ma Ling, Huan Sun, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
Does route of administration affect antidepressant efficacy of ketamine? A meta-analysis of double-blind randomized controlled trials comparing intravenous and intranasal administration
Marvin S. Meiering, David Weigner, Matti Gärtner, et al.
Journal of Psychiatric Research (2022) Vol. 156, pp. 639-646
Closed Access | Times Cited: 6
The effects of esketamine on the intestinal microenvironment and intestinal microbiota in mice
Ying Zhang, Wenhao Ma, Hao Lin, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 3
A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression
Amanda J. F. Tamman, Amit Anand, Sanjay J. Mathew
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 745-759
Closed Access | Times Cited: 5
Ketamine for Major Depressive Disorder
Sara Costi
Current topics in behavioral neurosciences (2023), pp. 131-147
Closed Access | Times Cited: 2
Midazolam Attenuates Esketamine-Induced Overactive Behaviors in Mice Before the Sedation, but Not During the Recovery
Qinjun Chu, Meng Mao, Yafan Bai, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 4
Exploring inner depths
Joost Breeksema
(2024)
Open Access
Ketamine in psychiatry
Grace Pham, Sanjay J. Mathew
Elsevier eBooks (2024), pp. 339-356
Closed Access
Results of esketamine administration in a Greek population; a case series
Petros Fotiadis, Eleni Tsalkitzi, Dimos Dimellis, et al.
Psychiatriki (2024)
Open Access
Perioperative Use of Esketamine for the Prevention of Postpartum Depression after Cesarean Section: A Meta-Analysis
Yanhong Li, Kangyu Zhao, Peipei Cao, et al.
(2024)
Closed Access
Ketamine Therapy in Complex Cases: A Cautionary Tale of Exacerbated Personality Traits and the Crucial Role of Comprehensive Follow‐Up and Psychosocial Interventions
Jai Ahuja, Luba Leontieva
Case Reports in Psychiatry (2024) Vol. 2024, Iss. 1
Open Access
APLICABILIDADE DA QUETAMINA EM DEPRESSÃO REFRATÁRIA E IDEAÇÃO SUICIDA: UMA REVISÃO INTEGRATIVA DE LITERATURA
Raylha Farias Tavares, Alisson Vasconcelos de Araújo, Bruno Castro Silva, et al.
Revista Ibero-Americana de Humanidades, Ciências e Educação (2024) Vol. 10, Iss. 8, pp. 3166-3174
Open Access
Facile fabrication of the immuno-MALDI-MS chip for the enrichment of abused drug in human urine integrated with MALDI-MS analysis
Hsin-Ping Chen, He‐Hsuan Hsiao
Analytica Chimica Acta (2024) Vol. 1329, pp. 343224-343224
Closed Access
Jiannao pills mitigate chronic restraint stress-induced anxiety in mice through the regulation of intestinal microflora
Pan Jia, Lihan Zhang, Jie Liu, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4549-4563
Closed Access

Scroll to top